葡萄糖胺在驱动癌症发病过程中的核心作用
Xueheng Zhao1,2, Manoj Kumar Pandey2,3
1Divisions of Pathology and Laboratory Medicine and Biomedical Informatics, Burnet Campus, 3333 Burnet Avenue, Cincinnati, OH 45229-3026, USA.
International journal of molecular sciences
|October 29, 2025
概括
葡萄糖胺 (GlcCer) 是一种生物活性脂质,与癌症的进展和药物耐药性有关. 向 GlcCer 合成可能会提供新的癌症疗法和瘤易感性疾病的生物标志物.
科学领域:
- 生物化学和分子生物学
- 癌症生物学和瘤学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 葡萄糖胺 (GlcCer) 是一种生物活性葡萄糖脂,由胺衍生而成.
- GlcCer的调节失调与诸如高氏病 (GD) 这样的溶酶体储存障碍有关.
- 新出现的证据突出显示了glcCer在癌症发病,进展和耐药性方面的作用.
研究的目的:
- 为了回顾最近在葡萄糖胺 (GlcCer) 生物学上的进展.
- 强调GlucCer在致癌性疾病和癌症中的作用.
- 探索GlcCer作为瘤学中的生物标志物和治疗点的潜力.
主要方法:
- 综合最近科学进展的文献综述.
- 分析葡萄糖胺 (GlcCer) 代谢及其相关的信号通路.
- 检查UDP-葡萄糖胺葡萄糖转移酶 (UGCG) 在癌症中的作用.
主要成果:
- 葡萄糖胺 (GlcCer) 促进癌细胞的存活,生长,转移和多药性耐药性.
- 在UDP-葡萄糖胺糖转移酶 (UGCG) 的异常上调驱动瘤性途径 (PI3K/Akt,MAPK,Wnt,NF-κB).
- 特定的GlcCer物种表现出组织依赖的功能,有助于致癌潜力.
- GlcCer代谢与炎症,氧化应激和改变葡萄糖利用有关.
结论:
- 葡萄糖胺 (GlcCer) 作为关键的代谢节点,连接遗传性疾病和恶性瘤.
- GlcCer在关键癌症途径中的参与表明其作为治疗点的潜力.
- 对GlucCer代谢的进一步研究可能会产生用于癌症诊断和治疗的新生物标志物.
相关概念视频
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


